This is the text extract for February Tender Notification; Contact: Notifications, browse documents here.

---

29 February 2012

TENDER RESULTS

The PHARMAC Board (or Acting Chief Executive under Delegated Authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2011/12 Invitation to Tender, dated 2 November 2011 and 2010/11 Invitation to Tender, dated 2 November 2010. As discussed in our 2010 tender consultation document, we are notifying tender decisions as they are made in 2012. This change is to provide maximum notification of upcoming changes to the market, specifically to incumbent suppliers. Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website – www.pharmac.govt.nz/schedule.asp. Where a product does not have a current pharmacode, suppliers are required to ensure a pharmacode has been received from the Pharmacy Guild of New Zealand before the 12th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct pharmacode.

A481549 - qA21977

Page 1 of 5

---

2011/12 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2015 Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

Current subsidy and price $16.08 $61.89 $4.60 $8.50

$9.75

The decisions were as follows:

Chemical name

Presentation; Pack size and type Tab 1 mg; 100 tablets, bottle Tab 4 mg; 100 tablets, bottle Tab 30 mg; 100 tablets, bottle Tab 60 mg; 100 tablets, bottle Eye drops 50 µg per ml; 2.5 ml OP, bottle/dropper

New subsidy and price $5.87 $8.16 $4.60 $8.50 $1.99

Sole supply brand (Supplier) Douglas (Douglas) Douglas (Douglas) Dilzem (Douglas) Dilzem (Douglas) Hysite (Pfizer)

Date of subsidy change

Sole Subsidised Supply date

Dexamethasone Dexamethasone Diltiazem hydrochloride Diltiazem hydrochloride Latanoprost

1 June 2012 1 June 2012 1 July 2012 1 July 2012 1 July 2012

1 September 2012 1 September 2012 1 October 2012 1 October 2012 1 October 2012

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

2. Tenders awarded to pharmaceuticals where no brand is listed.

Presentation; Pack size and type Tab 1 mg; 100 tablets, bottle Tab 4 mg; 100 tablets, bottle Eye drops 50 µg per ml; 2.5 ml, bottle/dropper Hospital Supply Brand (Supplier) Douglas (Douglas) Douglas (Douglas) Hysite (Pfizer) DV Limit 1% 1% 1%

The decisions were as follows:

Chemical Name Dexamethasone Dexamethasone Latanoprost

Pack price $5.87 $8.16 $1.99

Listing date 1 June 2012 1 June 2012 1 July 2012

Hospital Supply Status date 1 August 2012 1 August 2012 1 September 2012

A481549 - qA21977

Page 2 of 5

---

3.

Tenders awarded to listed pharmaceuticals where only the current brand is listed.

Chemical Name Diltiazem hydrochloride Diltiazem hydrochloride *Fludarabine Phosphate Presentation; Pack size and type Tab 30 mg; 100 tablets, bottle Tab 60 mg; 100 tablets, bottle Tab 10 mg; 20 tablets, Current pack price $4.60 $8.50 $867.00 New pack price $4.60 $8.50 $433.50 Hospital Supply Brand (Supplier) Dilzem (Douglas) Dilzem (Douglas) Fludara Oral (Sanofi) DV Limit 5% 5% 1% Date of price change 1 July 2012 1 July 2012 1 April 2012 Hospital Supply Status date 1 September 2012 1 September 2012 1 June 2012

The decisions were as follows:

* The price and subsidy for fludarabine phosphate (PCT only) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 April 2012.

4.

Tenders awarded to listed pharmaceuticals where at least one other brand is listed.

Presentation; Pack size and type Inj 2 mg per ml, 25 ml; 1 vial Inj 2 mg per ml, 50 ml; 1 vial Inj 2 mg per ml, 100 ml; 1 vial Inj 50 mg; 1 vial Inj 100 mg; 1 vial Current pack price $87.50 New pack price $39.38 Hospital Supply Brand (Supplier) DBL Epirubicin Hydrochloride (Hospira) DBL Epirubicin Hydrochloride (Hospira) DBL Epirubicin Hydrochloride (Hospira) Oxaliplatin Actavis 50 Oxaliplatin Actavis 100 DV Limit 1% Date of listing/price change for tender winning brand 1 June 2012 Hospital Supply Status date (and delisting of other listed brands) 1 August 2012 Brand (Supplier) to be delisted Epirubicin Ebewe (Sandoz) Epirubicin Ebewe (Sandoz) Epirubicin Ebewe (Sandoz) Oxaliplatin Ebewe (Sandoz) Oxaliplatin Ebewe (Sandoz)

The decisions were as follows:

Chemical Name

*Epirubicin

*Epirubicin

$125.00

$58.20

1%

1 June 2012

1 August 2012

*Epirubicin *Oxaliplatin *Oxaliplatin

$210.00 $55.00 $110.00

$94.50 $15.32 $25.01

1% 1% 1%

1 June 2012 1 June 2012 1 June 2012

1 August 2012 1 August 2012 1 August 2012

*Epirubicin and oxaliplatin (PCT Only) will be listed in Section B of the Pharmaceutical Schedule at the prices above from 1 June 2012.

A481549 - qA21977

Page 3 of 5

---

2010/11 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2014

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

5. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

Current subsidy and price $23.00 New subsidy and price $21.90

The decisions were as follows:

Chemical name

Presentation; Pack size and type Inj 10 mg per ml, 1 ml; 5 ampoules Inj 40 mg per ml, 1 ml; 5 ampoules

Sole supply brand (Supplier) Kenacort-A (Aspen) Kenacort-A40 (Aspen)

Date of subsidy change

Sole Subsidised Supply date

Triamcinolone acetonide Triamcinolone acetonide

1 April 2012

1 July 2012

$56.48

$53.79

1 April 2012

1 July 2012

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

6. Tenders awarded to listed pharmaceuticals where only the current brand is listed.

Chemical Name Triamcinolone acetonide Triamcinolone acetonide Presentation; Pack size and type Inj 10 mg per ml, 1 ml; 5 ampoules Inj 40 mg per ml, 1 ml; 5 ampoules Current pack price $23.00 $56.48 New pack price $21.90 $53.79 Hospital Supply Brand (Supplier) Kenacort-A (Aspen) Kenacort-A40 (Aspen) DV Limit 1% 1% Date of price change 1 April 2012 1 April 2012 Hospital Supply Status date 1 June 2012 1 June 2012

The decisions were as follows:

A481549 - qA21977

Page 4 of 5

---

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

The PHARMAC Board (or Chief Executive under Delegated Authority) resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2011/12 Invitation to Tender, dated 2 November 2011: Chemical Name Epirubicin Line Item Inj 2 mg per ml, 5 ml

For products included in the 2010/11 Invitation to Tender and 2011/12 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or Acting Chief Executive) approval. We will keep you informed of any updates regarding such tender products as decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A481549 - qA21977

Page 5 of 5